Sanofi and CD&R have signed a share purchase agreement for the sale of a 50% stake in the consumer health business.

Sanofi is closer to selling a 50% controlling stake in the consumer health business, Opella to private equity Clayton ...

Paris: Sanofi and CD&R have announced that they have signed the share purchase agreement in relation to the sale of a 50 ...

Partners in London and continental Europe from Linklaters, Kirkland & Ellis, Garrigues and Chiomenti have been named on a ...

The AdNews Agency Of The Year Award 2024 winners have been revealed. The awards were judged by senior marketers and CMOs from ...

In 2025’s go-go leveraged debt markets, everything is up for negotiation, but a trio of investor protections are proving to ...

Millie, a modern maternity clinic, secured $12 million in Series A funding led by existing investors RH Capital, TMV, ...

The pharma signed an agreement handing PE firm CD&R a 50% stake in its Capella unit. Elsewhere, Gilead and Ultragenyx secured ...

Health sector stocks fluctuate amid DOJ probe into UnitedHealth (UNH), Gilead upgrade for HIV treatments, and Moderna's focus on non-COVID approvals.